Abstract
Background: We seek to inform radiotherapy (RT) delivery for adenoid cystic carcinoma of the head and neck (ACC) by evaluating RT techniques and recurrence patterns. Methods: We identified patients with ACC treated with curative-intent RT from 2005 to 2021. Imaging was reviewed to determine local recurrence (LR). Results: Ninety-one patients were included. The 5-year LR risk was 12.2% (6.6–22.7). One patient each experienced a marginal and out-of-field recurrence. Patients receiving >60 Gy postoperatively had a 5-year LR risk of 0% compared to 10.7% (4.2–27.2) with ≤60 Gy. Those receiving 70 and <70 Gy definitively had a 5-year LR risk of 15.2% (2.5–91.6) and 33.3% (6.7–100.0), respectively. No patients had regional nodal failure. Conclusions: Modern, conformal RT for ACC results in low rates of LR. Doses >60 and 70 Gy may improve control in the postoperative and definitive settings, respectively. Elective nodal treatment can be omitted in well-selected patients.
Original language | English (US) |
---|---|
Pages (from-to) | 187-196 |
Number of pages | 10 |
Journal | Head and Neck |
Volume | 45 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2023 |
Keywords
- adenoid cystic carcinoma
- adjuvant radiotherapy
- conformal radiotherapy
- head and neck neoplasms
- intensity-modulated radiotherapy
ASJC Scopus subject areas
- Otorhinolaryngology